363
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Chronic pain management issues in the primary care setting and the utility of long-acting opioids

, MD
Pages 1823-1833 | Published online: 15 Jul 2010

Bibliography

  • Brunton S. Approach to assessment and diagnosis of chronic pain. J Fam Pract 2004;53(Suppl):S3-10
  • Smith BH, Hopton JL, Chambers WA. Chronic pain in primary care. Fam Pract 1999;16:475-82
  • Peter D Hart Research Associates. Americans talk about pain. A survey among adults nationwide conducted for Research America. Available from: http://www.researchamerica.org/polldata/2003/painpoll03.pdf. [Last accessed 28 November 2007]
  • Ashburn MA, Staats PS. Management of chronic pain. Lancet 1999;353:1865-9
  • Allen H, Hubbard D, Sullivan S. The burden of pain on employee health and productivity at a major provider of business services. J Occup Environ Med 2005;47:658-70
  • Otis JD, Keane TM, Kerns RD. An examination of the relationship between chronic pain and post-traumatic stress disorder. J Rehabil Res Dev 2003;40:397-405
  • Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull 1985;97:18-34
  • Deardorff W. Breaking the cycle of chronic pain and insomnia. Available from: http://www.spine-health.com/topics/conserv/insomnia/insomnia1.html. [Last accessed 21 February 2007]
  • Cohen MJM, Menefee LA, Doghramji K, Sleep in chronic pain: problems and treatments. Int Rev Psychiatry 2000;12:115-26
  • Katz WA. Musculoskeletal pain and its socioeconomic implications. Clin Rheumatol 2002;21:S2-4
  • Ortho-McNeil Pharmaceutical. 1999 National Pain Survey. Available from: http://www.chiro.org/LINKS/FULL/1999_National_Pain_ Survey.html. [Last accessed 21 February 2007]
  • Vorsanger GJ, Gallagher R. Negative impact of chronic pain on workers and employers. Poster presented at the 18th Annual Clinical Meeting of the American Academy of Pain Management, e27 – 30 September 2007; Las Vegas, NV, USA
  • Department of Health and Human Services, National Institutes of Health. New Directions in Pain Research: I. Available from: http://grants.nih.gov/grants/guide/pa-files/PA-98-102.html. [Last accessed 21 February 2007]
  • Americans Living with Pain Survey. Executive Summary of Results. Survey conducted on behalf of the American Chronic Pain Association. Sponsored by Endo Pharmaceuticals. April 2004. Available from: http://theacpa.org/documents/FINAL%20PAIN%20SURVEY%20RESULTS%20REPORT.pdf. [Last accessed 21 February 2007]
  • Podichetty VK, Mazanec DJ, Biscup RS. Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J 2003;79:627-33
  • Chronic Pain in America: Roadblocks to Relief. A study conducted by Roper Starch Worldwide for American Academy of Pain Medicine, American Pain Society and Janssen Pharmaceutica; 1999. Available from: http:// www.ampainsoc.org/links/roadblocks/. [Last accessed 21 February 2007]
  • McCarberg B, Lande SD. APS Managed Care Forum on Pain. Available from: http://www.ampainsoc.org/pub/ bulletin/may00/forum1.htm. [Last accessed 28 July 2008]
  • Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North America 2005;23:21-36
  • Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Minneap) 2000;35:45-52, 59
  • Drewes AM. Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis. Rheumatology (Oxf) 1999;38:1035-8
  • Drewes AM, Arendt-Nielsen L. Pain and sleep in medical diseases: interactions and treatment possibilities. A review. Sleep Res Online 2001;4:67-76
  • Kundermann B, Spernal J, Huber MT, Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-7
  • Atkinson JH, Slater MA, Patterson TL, Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study. Pain 1991;45:111-21
  • Davis MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging 2003;20:23-57
  • Gloth MJ, Matesi AM. Physical therapy and exercise in pain management. Clin Geriatr Med 2001;17:525-35, vii
  • American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
  • Wong M, Rietzschel J, Mulherin D, David C. Evaluation of a multidisciplinary outpatient pain management programme based at a community hospital. Musculoskeletal Care 2009;7:106-20
  • Stanos S, Houle TT. Multidisciplinary and interdisciplinary management of chronic pain. Phys Med Rehabil Clin N Am 2006;17:435-50, vii
  • Stanos SP, McLean J, Rader L. Physical medicine rehabilitation approach to pain. Med Clin North Am 2007;91:57-95
  • Adams EH, Breiner S, Cicero TJ, A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006;31:465-76
  • Ives TJ, Chelminski PR, Hammett-Stabler CA, Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46
  • Gilson AM, Kreis PG. The burden of the nonmedical use of prescription opioid analgesics. Pain Med 2009;10(Suppl 2):S89-100
  • Daniell HW. Opioid-induced androgen deficiency. Curr Opin Endocrinol Diabetes 2006;13:262-6
  • Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002;3:377-84
  • Fraser LA, Morrison D, Morley-Forster P, Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009;117:38-43
  • Abs R, Verhelst J, Maeyaert J, Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22
  • Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-31
  • Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004;100:851-8
  • Roberts LJ, Finch PM, Pullan PT, Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain 2002;18:144-8
  • Wisconsin Medical Society Task Force on Pain Management. Guidelines for the assessment and management of chronic pain. WMJ 2004;103:13-42
  • Trescot AM, Boswell MV, Atluri SL, Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39
  • Chou R, Fanciullo GJ, Fine PG, Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-46
  • Chou R, Fanciullo GJ, Fine PG, Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30
  • Myths and facts about long-acting opioids in chronic pain: a multidisciplinary analysis. ONS News 2004;19:55-6
  • Collett BJ. Chronic opioid therapy for non-cancer pain. Br J Anaesth 2001;87:133-43
  • Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
  • Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003;38:435-45
  • Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
  • Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician 2008;11:S155-80
  • Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008;24:497-508
  • Moore TM, Jones T, Browder JH, A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009;10:1426-33
  • Butler SF, Budman SH, Fernandez KC, Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J Addict Med 2009;3:66-73
  • Fishbain DA, Cole B, Lewis J, What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors?. A structured evidence-based review. Pain Med 2008;9:444-59
  • Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008;9:1098-106
  • AVINZA® (morphine sulfate extended-release capsules) [package insert]. Bristol, TN: King Pharmaceuticals, Inc.; 2006
  • Caldwell JR, Rapoport RJ, Davis JC, Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91
  • OPANA® ER (oxymorphone hydrochloride) extended-release tablets [package insert]. Chadds Ford, PA: Endo Pharmaceuticals Inc.; 2007
  • Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:357-66
  • Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-64
  • Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-8
  • OXYCONTIN® (oxycodone HCl controlled-release) tablets [package insert]. Stamford, CT: Purdue Pharma L.P.; 2007
  • Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-35
  • Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133-7
  • Roth SH, Fleischmann RM, Burch FX, Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-60
  • Caldwell JR, Hale ME, Boyd RE, Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-9
  • ULTRAM® ER (tramadol HCl) Extended-Release Tablets [package insert]. Raritan, NJ: PriCara™, a unit of Ortho-McNeil, Inc.; 2006
  • Babul N, Noveck R, Chipman H, Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59-71
  • Gana TJ, Pascual MLG, Fleming RRB, Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391-401
  • Noble M, Treadwell JR, Tregear SJ, Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; CD006605
  • Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No SMA 09-4434). Rockville, MD, USA. Available from: http://www.oas.samhsa.gov/ nsduhLatest.htm. [Last accessed 13 April 2010]
  • Substance Abuse and Mental Health Services Administration. Office of Applied Studies (5 February 2009). The NSDUH Report: trends in nonmedical use of prescription pain relievers: 2002 to 2007. Rockville, MD, USA. Available from: http://oas.samhsa.gov/2k9/painRelievers/ nonmedicalTrends.cfm. [Last accessed 13 April 2010]
  • Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999 – 2006. Available from: http://www.cdc.gov/nchs/data/databriefs/ db22.pdf. NCHS Data Brief 1 – 8 Sep 2009
  • Centers for Disease Control and Prevention. Overdose deaths involving prescription opioids among Medicaid enrollees – Washington, 2004 – 2007. MMWR Morb Mortal Wkly Rep 2009;58:1171-5
  • Kuehn BM. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA 2009;302:369-71
  • Ballantyne JC. U.S. Opioid risk management initiatives. IASP Pain Clin Updat 2009;17:1-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.